Old Web
English
Sign In
Acemap
>
authorDetail
>
Jhon A. Marin Soto
Jhon A. Marin Soto
VU University Amsterdam
Daratumumab
Multiple myeloma
Effector
Ex vivo
Antibody
2
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients
2021
Cancers
Kristine A. Frerichs
Christie P.M. Verkleij
Meletios A. Dimopoulos
Jhon A. Marin Soto
Sonja Zweegman
Mary H. Young
Kathryn J. Newhall
Tuna Mutis
Niels W.C.J. van de Donk
Show All
Source
Cite
Save
Citations (3)
Preclinical activity of JNJ-7957, a novel BCMAxCD3 bispecific antibody for the treatment of multiple myeloma, is potentiated by daratumumab
2020
Clinical Cancer Research
Kristine A. Frerichs
Marloes E.C. Broekmans
Jhon A. Marin Soto
Berris van Kessel
Martijn W. Heymans
Lisa C. Holthof
Christie P.M. Verkleij
Rengasamy Boominathan
Bhavesh Vaidya
Jocelyn Sendecki
Amy Axel
Francois Gaudet
Kodandaram Pillarisetti
Sonja Zweegman
Homer Adams
Tuna Mutis
Niels W.C.J. van de Donk
Show All
Source
Cite
Save
Citations (26)
1